Asset Management One
LRMR icon

Asset Management One’s Larimar Therapeutics LRMR Stock Holding History

Asset Management One’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-10,087
Closed -$3.78M – 1357
2015
Q3 		$3.78M Sell
10,087
-1,108
-10% -$500K 0.06% 412
2015
Q2 		$4.55M Buy
11,195
+997
+10% +$417K 0.06% 393
2015
Q1 		$4.91M Buy
+10,198
New +$4.84M 0.06% 398

Other funds holding LRMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return

Asset Management One's LRMR Position: Q4 2015 in Review

Asset Management One sold out of Larimar Therapeutics (LRMR) in Q4 2015, closing a stake of 10,087 shares — an estimated $3.78M sold.

Asset Management One first reported a position in LRMR in Q1 2015 and held it in 3 quarters. The position peaked at $4.91M in Q1 2015. 87 funds tracked by Wall St. Rank hold LRMR as of Q4 2015.

  • Asset Management One reported no remaining Larimar Therapeutics position as of Q4 2015 after selling out during the quarter.
  • Asset Management One sold 10,087 Larimar Therapeutics shares in Q4 2015, an estimated $3.78M.
  • Asset Management One first reported a position in Larimar Therapeutics in Q1 2015 and held it in 3 quarters.
  • Asset Management One's Larimar Therapeutics position peaked at $4.91M in Q1 2015.
  • 87 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q4 2015.

Based on Asset Management One's 13F filing for Q4 2015, filed 28 Jan 2016.